Arena Pharma (ARNA) Enters $35.5M Private Placement
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) has entered an agreement to sell 12.15 million common shares at $1.46 per share.
Arena also signed to sell 12,150 shares of its Series C Convertible Preferred Stock, at a price of $1,460 per share.
The sale is being made to affiliates of Deerfield Management.
Gross proceeds of $35.5 million are expected.
Arena will use approximately $17.7 million of the proceeds from this offering to prepay a portion of the loan principal that otherwise would have been required to be repaid in June 2013 under the existing Facility Agreement between Arena and Deerfield.
Arena also signed to sell 12,150 shares of its Series C Convertible Preferred Stock, at a price of $1,460 per share.
The sale is being made to affiliates of Deerfield Management.
Gross proceeds of $35.5 million are expected.
Arena will use approximately $17.7 million of the proceeds from this offering to prepay a portion of the loan principal that otherwise would have been required to be repaid in June 2013 under the existing Facility Agreement between Arena and Deerfield.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Water Resources raises $20M through stock sale and credit line
- GoPro to merge with Starman Optical in $285M recapitalization deal
- Can-Am to provide $150,000 and vehicles to Farm Rescue over three years
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Deerfield ManagementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
